Vimarsana
Biggest News Aggregation in the World

Page 2 - Schulhoff Co News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Schulhoff Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Schulhoff Co Today - Breaking & Trending Today

Medpace (NASDAQ:MEDP) Stock Price Down 0.3% - Vimarsana News

Medpace (NASDAQ:MEDP) Stock Price Down 0.3%

Medpace Holdings, Inc. (NASDAQ:MEDP – Get Free Report) shares traded down 0.3% during mid-day trading on Wednesday . The stock traded as low as $386.42 and last traded at $387.29. 39,505 shares changed hands during trading, a decline of 84% from the average session volume of 247,935 shares. The stock had previously closed at $388.35. […]

abrdn plc Purchases Shares of 708,303 Pyxis Oncology, Inc. (NASDAQ:PYXS) - Vimarsana News

abrdn plc Purchases Shares of 708,303 Pyxis Oncology, Inc. (NASDAQ:PYXS)

Abrdn plc acquired a new position in Pyxis Oncology, Inc. (NASDAQ:PYXS – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 708,303 shares of the company’s stock, valued at approximately $1,275,000. Several other large investors have also recently modified their […]

Medpace (NASDAQ:MEDP) Lifted to "Buy" at Jefferies Financial Group - Vimarsana News

Medpace (NASDAQ:MEDP) Lifted to "Buy" at Jefferies Financial Group

Jefferies Financial Group upgraded shares of Medpace (NASDAQ:MEDP – Free Report) from a hold rating to a buy rating in a research report report published on Tuesday, MarketBeat.com reports. They currently have $450.00 price objective on the stock, up from their prior price objective of $340.00. MEDP has been the subject of several other reports. […]

Guggenheim Increases Medpace (NASDAQ:MEDP) Price Target to $464.00 - Vimarsana News

Guggenheim Increases Medpace (NASDAQ:MEDP) Price Target to $464.00

Medpace (NASDAQ:MEDP – Get Free Report) had its price target lifted by research analysts at Guggenheim from $453.00 to $464.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Guggenheim’s price objective indicates a potential upside of 17.34% from the company’s […]

Source: wkrb13.com
Guggenheim Increases Medpace (NASDAQ:MEDP) Price Target to $464.00 - Vimarsana News

Guggenheim Increases Medpace (NASDAQ:MEDP) Price Target to $464.00

Medpace (NASDAQ:MEDP – Get Free Report) had its price target lifted by research analysts at Guggenheim from $453.00 to $464.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Guggenheim’s price objective indicates a potential upside of 17.34% from the company’s […]